• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Plexxikon Inc.

Headquarters: Berkeley, CA, United States of America
Website: N/A
Year Founded: 2000
Status: Acquired

BioCentury | Nov 1, 2023
Management Tracks

Genentech’s Hardy to become CEO at BioMarin

Plus: BMS CEO Boerner appointed chair, and updates from Storm, Amarin, CTRL, Lakewood, Vesica and RS
BioCentury | Mar 11, 2023
Emerging Company Profile

Opna Bio: targeting FMRP to treat cancer

Company’s other five small molecules come from CEO Gideon Bollag’s former company, Plexxikon
BioCentury | Nov 30, 2022
Discovery & Translation

Acuitas’ pan-influenza mRNA vaccine; plus Opna links FMR1 to cancer and more

BioCentury’s roundup of translational news
BioCentury | Nov 22, 2022
Finance

Nov. 21 Quick Takes: Oncology company Opna launches with $38M

Plus: FogPharma raises another $178M and updates from Genmab and Replay
BioCentury | Nov 18, 2021
Management Tracks

D’Amelio to retire as Pfizer’s CFO

Plus: BioAge, bit bio, Volastra, Provention and more
BioCentury | Jul 2, 2021
Management Tracks

McKinsey alums Santos da Silva, Bodenstedt join MoonLake; plus Takeda, Plexxikon, Solid, EQRx, Cardior and more

Two months after Merck KGaA (Xetra:MRK) teamed up with BVF Partners to launch MoonLake Immunotherapeutics AG, the newco has hired McKinsey veterans Jorge Santos da Silva as CEO and
BioCentury | May 24, 2019
Product Development

Why quizartinib hiccup at ODAC shouldn’t derail Daiichi’s 2025 cancer drug goals

Despite ODAC’s snub of quizartinib, Daiichi has several moves to make its 2025 cancer drug goals
BioCentury | Dec 2, 2015
Company News

Management tracks

Items per page:
1 - 10 of 190
Help Center
Username
Request a Demo
Request Training
Ask a Question